AkzoNobel has unveiled a five-year research partnership with the University of Manchester (Manchester, U.K.) to investigate the science of anti-corrosion coatings. When the research begins April 1 of this year it will be the world’s largest academic...
Odfjell says net losses in the fourth quarter of 2011 were $8 million, exactly the same net result as in the fourth quarter of 2010. Odjfell's sales and Ebitda increased 19% and 11% year over year, to $322 million and $31 million, respectively, in the fourth...
Mexichem (Tlalnepantla, Mexico) says it has agreed to acquire 100% of Wavin (Zwolle, the Netherlands) for approximately €531 million ($704 million). Mexichem intends to make a cash offer of €10.50 per Wavin ordinary share. The offer represents...
Kemira says net profit from continuing operations in the fourth quarter of 2011 was €37.8 million ($50 million), 51% higher than the €25.1 million reported in the same quarter of 2010. Earnings per share (EPS) also increased 60% year over year, to...
Rusal (Moscow), the global leading producer of aluminum, and fertilizer producer PhosAgro today announced an agreement for the supply of increased quantities of aluminum fluoride by PhosAgro to Rusal until 2034. This long-term agreement will lead to...
Rhodia, a subsidiary of Solvay, says it has signed a joint development agreement (JDA) with Roquette (Lestrem, France) to develop new plant-based polymers. Each company will have the opportunity, through the JDA, to leverage synergies bringing together...
Yara (Oslo), the global fertilizer major, today reported strong fourth-quarter results, reflecting “good farm profitability and improved margins." It also said that the 2011 annual results are the highest in history. Fourth-quarter net...
BP says that earnings on a replacement cost basis, before interest and taxes, for its petrochemical business in the fourth quarter of 2011 were $96 million, 60% lower than the $243 million reported in the same quarter of 2010. Sales figures were not disclosed but...
Aesica Pharmaceuticals (Newcastle upon Tyne, U.K.), a provider of active pharma ingredients (API), formulations, and custom synthesis, says it plans to upgrade its API manufacturing facilities, enabling it to manufacture high potency APIs (HPAPIs) at...